Samuel Deutsch

Chief Scientific Officer @ Nutcracker Therapeutics arrow icon

Known information

  • Led the DNA synthesis platform at the Joint Genome Institute, part of Lawrence Berkeley National Laboratory
  • Conducted research in molecular hematology at the Geneva University Hospital
  • Worked in cancer genomics at the World Health Organization
  • Holds a B.Sc. in Genetics from the University of Nottingham
  • Received a Ph.D. from the University of Geneva
  • Author of over 75 peer-reviewed papers

About Nutcracker Therapeutics

Nutcracker Therapeutics is a biotechnology company focused on developing RNA-based treatments using a proprietary platform that combines advanced engineering with high-precision biosynthesis and microfluidic technology.

report flag Report inaccurate information

People similar to Samuel Deutsch

Benjamin Eldridge

Co-founder and Chief Technology Officer @ Nutcracker Therapeutics

Guna Kannan

Senior Vice President, Protein Engineering @ Nutcracker Therapeutics

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free